Kyntra Bio, Inc. (KYNB)
7.39
+0.31
(+4.38%)
USD |
NASDAQ |
Apr 14, 16:00
7.39
0.00 (0.00%)
After-Hours: 19:45
Kyntra Bio EPS Diluted (Quarterly) : -3.611 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | -0.0772 |
| GT Biopharma, Inc. | -4.413 |
| Gossamer Bio, Inc. | -0.2085 |
| Monte Rosa Therapeutics, Inc. | -0.7039 |
| Septerna, Inc. | -0.2409 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.61M |
| Revenue (Quarterly) | 1.277M |
| Total Expenses (Quarterly) | 15.89M |
| Enterprise Value | -6.289M |
| Gross Profit Margin (Quarterly) | 77.60% |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | 423.1% |
| Normalized Earnings Yield | 439.55 |